SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
Study shows cells in cellular bone matrix products did not improve fusion SeaSpine’s DBM outperformed the tested CBM products. CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:...